Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Symetis
223
Symetis
Technology
Biotechnology
Symetis is a Swiss company developing minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases.
Suggest edits
Raised
$25.8M
Follow us
Also headquartered in Lausanne
Gamaya
SOLAR IMPULSE
Automation Anywhere
Supermicro
Foot Locker
Needle, Inc.
Vinny
Astrocast
WayRay
EPFL
Companies in the same industry
Radient Technologies
AngioChem
3P Biopharmaceuticals
AndersonBrecon
BrainCells
Consano
Mucosis
Ahura Scientific
BioTime
EternoGen
Alexa global traffic share
Overview
Funding
2
Add info
Acquired by
2
30 Mar 2017
Boston Scientific
$435,000,000
Latest funding
Undisclosed amount
Venture capital (Series D) - 2012
$25,800,000
Venture capital (Series C) - 2010
Location
Lausanne
,
Switzerland
Headquarters
Explore Lausanne
$435,000,000
PE HUB
,
Xconomy
Boston Scientific to buy Symetis for $435 mln
Health
Apps & Services
